Article
Functional reassessment of P16 variants using a transfection-based assay.
International journal of cancer - 19 Jul 1999
Walker G J, Gabrielli B G, Castellano M, Hayward N K
Abstract excerpt
CDKN2A appears to be the major melanoma susceptibility gene, and is also mutated/deleted in sporadic tumours of various types including melanoma. Thus far most approaches to assessing the functionality of mutations in this gene have used in vitro methods such as CDK4 binding and kinase inhibition assays, with sometimes disparate conclusions about functional significance of some variants between studies. We have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
